Sentinel Oncology awarded grant to further cancer research

Sentinel Oncology are pleased to announce that they have recently been awarded a development grant from the East of England Development Agency to further explore new areas of cancer research.

The grant will support the development of new pre-clinical molecules targeting DNA repair pathways and will ultimately lead to new treatments for common cancers such as breast, ovarian and glioblastoma.

 
Previous
Previous

Sentinel Oncology awarded Biomedical Catalyst funding to develop cancer drug

Next
Next

Sentinel Oncology Appoints John Dixon To Board Of Directors